Full text
PDFPage 572
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Amery A., Lijnen P. Alterations in lipid metabolism induced by antihypertensive therapy. Drugs. 1988;36 (Suppl 2):1–5. doi: 10.2165/00003495-198800362-00002. [DOI] [PubMed] [Google Scholar]
- Collins R., Peto R., MacMahon S., Hebert P., Fiebach N. H., Eberlein K. A., Godwin J., Qizilbash N., Taylor J. O., Hennekens C. H. Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990 Apr 7;335(8693):827–838. doi: 10.1016/0140-6736(90)90944-z. [DOI] [PubMed] [Google Scholar]
- Falch D. K., Schreiner A. The effect of spironolactone on lipid, glucose and uric acid levels in blood during long-term administration to hypertensives. Acta Med Scand. 1983;213(1):27–30. doi: 10.1111/j.0954-6820.1983.tb03684.x. [DOI] [PubMed] [Google Scholar]